A single dose pharmacokinetic study of insulin aspart was performed in 24 subjects with hepatic function ranging from normal to severely impaired.
Aspartinsuliini üksikannuse farmakokineetikat uuriti 24 isikul, kelle maksatalitlus varieerus normaalsest kuni tugevasti kahjustatuni.